Diploma PLC (LON:DPLM - Get Free Report) insider Katie Bickerstaffe acquired 246 shares of the stock in a transaction that occurred on Wednesday, September 23rd. The stock was purchased at an average cost of GBX 7,696 per share, with a total value of £18,932.16.
Katie Bickerstaffe also recently made the following trade(s):
- On Thursday, July 16th, Katie Bickerstaffe acquired 47 shares of Diploma stock. The shares were purchased at an average price of GBX 7,050 per share, for a total transaction of £3,313.50.
- On Thursday, July 16th, Katie Bickerstaffe purchased 133 shares of Diploma stock. The stock was acquired at an average cost of GBX 7,048 per share, with a total value of £9,373.84.
Diploma Stock Performance
Shares of Diploma stock traded down GBX 35 on Wednesday, reaching GBX 7,590. 15,308,292 shares of the company were exchanged, compared to its average volume of 2,761,334. The company has a debt-to-equity ratio of 47.65, a quick ratio of 0.80 and a current ratio of 2.06. The firm has a market cap of £10.18 billion, a price-to-earnings ratio of 53.91, a P/E/G ratio of 2.82 and a beta of 0.92. Diploma PLC has a 1-year low of GBX 4,970 and a 1-year high of GBX 7,765. The company's 50-day moving average is GBX 7,316.91 and its two-hundred day moving average is GBX 6,853.77.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on DPLM shares. Royal Bank Of Canada reaffirmed an "outperform" rating and set a GBX 7,400 target price on shares of Diploma in a report on Tuesday, September 8th. Berenberg Bank reaffirmed a "buy" rating and set a GBX 9,000 price target on shares of Diploma in a research note on Monday, July 20th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 7,000 price objective on shares of Diploma in a report on Friday, May 29th. Finally, JPMorgan Chase & Co. increased their target price on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an "overweight" rating in a research report on Monday, August 24th. Six research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Diploma has a consensus rating of "Moderate Buy" and an average target price of GBX 7,400.
View Our Latest Research Report on Diploma
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.